Anti-pd-1 antibodies and uses thereof
AssigneeTayu Huaxia Biotech Medical Group Co., Ltd.
InventorsLieping CHEN, Liqun LUO
Life of this patent
Estimating the term…
Abstract
Provided are anti-PD-1 antibodies or fragments thereof. In various example, the antibodies or fragments thereof includes a heavy chain variable region comprising heavy chain complementarity determining regions HCDR1, HCDR2, and HCDR3, and a light chain variable region comprising light chain complementarity determining regions LCDR1, LCDR2, and LCDR3. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer, infection or immune disorders are also provided.
Claims27
-24. (canceled)
One or more nucleic acids or polynucleotides encoding an antibody or fragment thereof having specificity to a human programmed cell death protein 1 (PD-1), wherein the antibody or fragment thereof comprises a heavy chain variable region comprising heavy chain complementarity determining regions HCDR1, HCDR2, and HCDR3, and a light chain variable region comprising light chain complementarity determining regions LCDR1, LCDR2, and LCDR3, wherein the HCDR1, HCDR2, HCDR3, LCDR1, LCDR2, and LCDR3 are selected from the group consisting of:
- (SEQ ID NO:
- 18)
- (a) HCDR1:
- GFTFSSYT (SEQ ID NO:
- 1), HCDR2:
- ISHGGGDT (SEQ ID NO:
- 2),
- HCDR3:
- ARHSGYERGYYYVMDY (SEQ ID NO:
- 3), LCDR1:
- ESVDYYGFSF (SEQ
- ID NO:
- 4), LCDR2:
- AAS, LCDR3:
- QQSKEVPW (SEQ ID NO:
- 6);
- (b) HCDR1:
- GYTFTSYT (SEQ ID NO:
- 7), HCDR2:
- INPTTGYT (SEQ ID NO:
- 8),
- HCDR3:
- ARDDAYYSGY (SEQ ID NO:
- 9), LCDR1:
- ENIYSNL (SEQ ID NO:
- 10),
- LCDR2:
- AAK, LCDR3:
- QHFWGTPWT (SEQ ID NO:
- 12);
- and
- (c) HCDR1:
- GFAFSSYD (SEQ ID NO:
- 13), HCDR2:
- ITIGGGTT (SEQ ID NO:
- 14),
- HCDR3:
- ARHRYDYFAMDN (SEQ ID NO:
- 15), LCDRI:
- ENVDNYGINF (SEQ ID
- NO:
- 16), LCDR2:
- VSS, LCDR3:
- QQSKDVPW
A composition comprising an antibody or fragment thereof, wherein the antibody or fragment thereof having specificity to a human programmed cell death protein 1 (PD-1), wherein the antibody or fragment thereof comprises a heavy chain variable region that is encoded by SEQ ID NO:
- 36;
- and a light chain variable region that is encoded by SEQ ID NO:
- 46.
Dependencies are inferred from the claim text.